Neurostimulation devices for chronic pain: a practical guide
Chronic pain affects roughly one in five Australians, and for many it lingers well beyond the expected healing window of an injury or surgery. When tablets, physiotherapy and targeted injections no longer keep the discomfort under control, a different kind of intervention begins to make sense. Neurostimulation is one of those interventions, and it has been quietly transforming the daily lives of people with stubborn nerve-related pain for decades.
This guide walks through what these small implanted or wearable devices actually do, who tends to benefit, and what the journey looks like inside the Australian healthcare system. It also compares neurostimulation with other common pain treatments, including some that fall under the broader neurosurgical umbrella.
How neurostimulation interrupts pain signals
Pain is not just a sensation in the body part that hurts; it is a message that travels up the spinal cord and into the brain. Neurostimulation devices work by sending gentle, competing electrical pulses into the nerves carrying those messages. The idea, often called gate control theory, is that a pleasant tingling or a sensation you barely notice can effectively crowd out the pain signal before it reaches consciousness.
Modern implantable systems are remarkably compact. A thin lead is positioned next to the spinal cord or near a peripheral nerve, then connected to a small pulse generator tucked under the skin of the lower back or abdomen. The patient carries a handheld controller to turn the system on, adjust intensity, or switch between programmes designed for different activities, from a desk job in Brisbane's CBD to a long-haul flight from Perth.
The main device families
Several categories of neurostimulation are used in clinical practice today. Spinal cord stimulators are the most common, with leads placed in the epidural space to cover pain in the back, legs, or trunk. Peripheral nerve stimulators target a specific nerve, such as the one running down the leg in cases of stubborn sciatica. Dorsal root ganglion stimulators are a more focused variant, useful when pain sits in a precise dermatome, such as after groin or knee surgery.
For people who want to avoid surgery altogether, transcutaneous electrical nerve stimulation, or TENS, uses adhesive pads on the skin and is widely available at pharmacies across Melbourne and Adelaide. It is cheaper and non-invasive, but the relief tends to be shorter-lived. In Australia, all medical-grade implantable neurostimulators must be listed on the Australian Register of Therapeutic Goods before a surgeon can offer them, which adds a layer of safety assurance for patients.
Conditions that respond well
Neurostimulation is generally reserved for neuropathic pain, meaning pain arising from damage or irritation of the nervous system itself rather than from ongoing tissue injury. Classic indications include failed back surgery syndrome, where discomfort persists after one or more spinal operations, and complex regional pain syndrome, a notoriously difficult condition that can affect an arm or leg after even a minor injury.
Diabetic peripheral neuropathy, persistent sciatica, and post-herpetic neuralgia, the burning pain that can follow shingles, are also common reasons clinicians raise the idea. For patients whose pain stems from structural problems inside the skull, the picture is different, and treatment usually involves a dedicated surgical team such as the surgeons who treat skull base tumors.
What the implantation journey looks like
Almost every patient starts with a trial. Temporary leads are placed through a needle, connected to an external battery, and worn for about a week to ten days. If pain drops by half or more and the sensation is tolerable, the trial is deemed successful and a permanent system is implanted a few weeks later. The full procedure is usually done under sedation and takes one to two hours.
Recovery is generally quick. Most people are up and walking within a day and resume light duties within two weeks. Heavy lifting is restricted for around six weeks to allow the leads to settle. Throughout this period, the clinical team fine-tunes the programming to suit the patient's lifestyle, whether that means gardening in Hobart's cooler climate or swimming laps at a Sydney ocean pool.
Living with an implanted system day to day
Modern rechargeable batteries can last up to a decade before needing replacement, and the handheld remote lets patients tweak settings on the fly. There are a few everyday adjustments worth knowing about. Airport security gates and the walk-through scanners used at major Australian venues can interact with the device, so patients carry an identification card and request a hand-held wand or pat-down instead.
Most modern systems are now MRI-conditional, meaning scans of certain body parts are safe under specific protocols. Strong magnets, certain industrial equipment, and some physiotherapy machines can interfere with stimulation, so a quick conversation with any new clinician goes a long way. Many users report that within a few months the device feels like a normal part of life.
Access, costs, and the Australian pathway
In Australia, neurostimulation is offered through both the public and private systems. Private health insurers with appropriate hospital cover often fund a significant portion of the device and admission costs, although out-of-pocket gaps vary widely between funds and policies. In the public system, waiting lists can stretch beyond a year in some states, which is why many choose the private route once conservative measures have failed.
A referral from a GP to a pain specialist or neurosurgeon is the usual starting point. Most specialists will want to see documented trials of medication, physiotherapy, and image-guided injections before recommending an implant. The Pharmaceutical Benefits Scheme keeps the cost of many pain medicines down, but for those who have already cycled through several without success, neurostimulation can be a cost-effective alternative over the long term, particularly when it reduces reliance on tablets and frequent clinic visits.
How neurostimulation stacks up against other options
When pain has not responded to first-line treatments, patients and clinicians typically weigh three or four options side by side: long-term medication, targeted procedures, further surgery, or a neuromodulation implant. Each has strengths and trade-offs, and the right answer depends on the type of pain, the underlying diagnosis, and the patient's preferences.
| Option | How it works | Best suited to | Key limitations |
|---|---|---|---|
| Spinal cord stimulation | Implanted leads send pulses to the spinal cord | Neuropathic leg or back pain, failed back surgery syndrome | Surgical risks, eventual battery replacements, MRI restrictions |
| Peripheral nerve stimulation | Lead sits beside a specific nerve | Localised nerve pain after injury or surgery | Narrow coverage area, requires precise lead placement |
| Dorsal root ganglion stimulation | Targets the sensory nerve cell cluster | CRPS, groin pain, focal limb pain | Technically demanding, fewer device choices |
| Vertebroplasty or kyphoplasty | Bone cement stabilises a vertebral compression fracture | Acute pain from osteoporotic spinal fractures | Does not help chronic neuropathic pain; the structural details in vertebroplasty vs kyphoplasty explain when each is appropriate |
| Long-term medication | Tablets such as gabapentinoids, opioids, or antidepressants | Diffuse or widespread pain | Side effects, tolerance, limited long-term benefit |
| Physical therapy and exercise | Restores movement, strengthens support muscles | Mechanical back pain, deconditioning | Less effect on established neuropathic pain |
A useful rule of thumb is that neurostimulation tends to shine when pain is neuropathic and well-localised, while movement-based therapies and weight management remain the foundation for mechanical pain. For vertebral compression fractures and certain structural problems, cement-based procedures fill a different niche entirely, and a specialist can explain when each approach is appropriate.
If chronic nerve pain is shaping your daily life and conservative measures have run their course, the next step is a careful assessment by an experienced neurosurgical team. The specialists at Ocala Neurosurgical Center work through the diagnostic process, discuss whether a trial of neurostimulation is reasonable, and coordinate the programming and follow-up care that determines whether the technology will actually deliver relief in everyday settings.